Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.10.059Source: DataRank Database

Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2021). On theSindex it has a DataRank of 0. It has been cited 62 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access62 citations

Free full text

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 5.25)OA: hybridTopics (34)Linked Datasets (3)DataCite Reuse (3)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Elisabeth H. Bel ORCID,Arnaud Bourdin ORCID,Ignacio Dávila ORCID,John Aubrey Douglass ORCID,J. Mark FitzGerald ORCID

Live enrichment

PubMed:34763123 OpenAlex:https://openalex.org/W3213573559

Canadian Institutes of Health Research

Grant: unidentified

unidentified

FWCI

5.25

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttp://www.jaci-inpractice.org/article/S2213219821012496/pdf

publisherhttp://www.jaci-inpractice.org/article/S2213219821012496/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2213219821012496?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213219821012496?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jaip.2021.10.059

Fields of Study

Asthma and respiratory diseasesRespiratory and Cough-Related ResearchInhalation and Respiratory Drug Delivery0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

AdultAsthmaBiological ProductsEosinophilsExpert TestimonyHumansNitric OxideExhalation

Keywords

MedicineExhaled nitric oxideAsthmaIntensive care medicineBiomarkerClinical trialExpert opinionInternal medicineAdultSevere asthmaBiological Products610Nitric OxideAlgorithmEosinophilsExhalation616[SDV.MHEP.PSR] Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractHumans[SDV.IMM.ALL] Life Sciences [q-bio]/Immunology/Allergology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study

10.6084/m9.figshare.24217418.v1figshare

Additional file 1 of Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study

10.6084/m9.figshare.24217418.v2figshare

Additional file 1 of Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study

10.6084/m9.figshare.24217418figshare